Overview

Early-onset Ventilator-associated Pneumonia in Adults: Comparison of 8 Versus 15 Days of Antibiotic Treatment

Status:
Completed
Trial end date:
2002-11-01
Target enrollment:
Participant gender:
Summary
The duration of treatment of community acquired pulmonary infection varies between 5 and 14 days according to the authors (22), or even 3 days with new drugs having long half-life (2). For nosocomial pulmonary infection, treatment durations are not standardized (5). It is simply mentioned the concept of "usual" treatment of at least 15 days. However, recent studies used 10 days of treatment without significant decrease in the rate of healing compared to usual treatment. It is essential to clarify the optimal duration of antibiotic treatment. Indeed, any excessive extension of treatment may increase the occurrence of adverse effects (renal toxicities, hepatic...), and induce resistance of bacteria to antibiotics (selection pressure), colonization of the patient by Multiresistant bacteria and an increase in the cost of treatment
Phase:
Phase 4
Details
Lead Sponsor:
Centre Hospitalier Universitaire de Besancon
Collaborators:
French Society for Intensive Care
GlaxoSmithKline
SmithKline Beecham
Treatments:
Amoxicillin
Amoxicillin-Potassium Clavulanate Combination
Anti-Bacterial Agents
Antibiotics, Antitubercular
beta-Lactams
Cefotaxime
Cefoxitin
Ceftriaxone
Clavulanic Acid
Clavulanic Acids
Lactams
Netilmicin
Tobramycin